{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T07:52:17Z","timestamp":1789199537783,"version":"build-2803163510"},"reference-count":25,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.clml.2018.06.022","type":"journal-article","created":{"date-parts":[[2018,6,26]],"date-time":"2018-06-26T21:26:57Z","timestamp":1530048417000},"page":"687-691","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Utility of PET-CT for Evaluation of Patients With Peripheral T-cell Lymphoma"],"prefix":"10.1016","volume":"18","author":[{"given":"Ronit","family":"Gurion","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Bernstine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liran","family":"Domachevsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmela","family":"Michelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pia","family":"Raanani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liat","family":"Vidal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzippy","family":"Shochat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anat","family":"Gafter-Gvili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clml.2018.06.022_bib1","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.clml.2018.06.022_bib2","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/ajh.24791","article-title":"The aggressive peripheral T cell lymphomas 2017","volume":"92","author":"Armitage","year":"2017","journal-title":"Am J Hematol"},{"key":"10.1016\/j.clml.2018.06.022_bib3","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/1097-0142(20010301)91:5<889::AID-CNCR1078>3.0.CO;2-5","article-title":"2-(Fluorine-18)fluoro-2-deoxy-d-glucose positron emission tomography in the detection and staging of malignant lymphoma: a bicenter trial","volume":"91","author":"Buchmann","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.clml.2018.06.022_bib4","first-page":"475","article-title":"The predictive value of positron emission tomography scanning performed after two courses of standard therapy on treatment outcome in advanced stage Hodgkin\u2019s disease","volume":"91","author":"Gallamini","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.clml.2018.06.022_bib5","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/bjh.12715","article-title":"The prognostic value of interim positron emission tomography scan in patients with classical Hodgkin lymphoma","volume":"165","author":"Oki","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clml.2018.06.022_bib6","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1182\/blood-2005-06-2252","article-title":"FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma","volume":"107","author":"Hutchings","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.clml.2018.06.022_bib7","doi-asserted-by":"crossref","first-page":"333","DOI":"10.2214\/AJR.09.3665","article-title":"Characterization of T-cell lymphomas by FDG PET\/CT","volume":"195","author":"Feeney","year":"2010","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.clml.2018.06.022_bib8","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1093\/annonc\/mdv010","article-title":"Utility of 18fluoro-deoxyglucose positron emission tomography for prognosis and response assessments in a phase 2 study of romidepsin in patients with relapsed or refractory peripheral T-cell lymphoma","volume":"26","author":"Horwitz","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clml.2018.06.022_bib9","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1634\/theoncologist.2013-0463","article-title":"Prognostic value of interim positron emission tomography in patients with peripheral T-cell lymphoma","volume":"19","author":"Pellegrini","year":"2014","journal-title":"Oncologist"},{"key":"10.1016\/j.clml.2018.06.022_bib10","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1002\/ajh.24128","article-title":"Utility of interim and end-of-treatment PET\/CT in peripheral T-cell lymphomas: a review of 124 patients","volume":"90","author":"El-Galaly","year":"2015","journal-title":"Am J Hematol"},{"key":"10.1016\/j.clml.2018.06.022_bib11","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00277-014-2227-5","article-title":"Post-therapy 18F-fluorodeoxyglucose positron emission tomography for predicting outcome in patients with peripheral T cell lymphoma","volume":"94","author":"Tomita","year":"2015","journal-title":"Ann Hematol"},{"key":"10.1016\/j.clml.2018.06.022_bib12","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1200\/JCO.2013.54.8800","article-title":"Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification","volume":"32","author":"Cheson","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clml.2018.06.022_bib13","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1080\/10428190903040048","article-title":"Report on the first international workshop on interim-PET scan in lymphoma","volume":"50","author":"Meignan","year":"2009","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2018.06.022_bib14","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1053\/j.semnuclmed.2017.09.002","article-title":"Interim FDG-PET imaging in lymphoma","volume":"48","author":"Gallamini","year":"2018","journal-title":"Semin Nucl Med"},{"key":"10.1016\/j.clml.2018.06.022_bib15","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.1200\/JCO.2007.11.6525","article-title":"Early interim 2-[18F]fluoro-2-deoxy-d-glucose positron emission tomography is prognostically superior to international prognostic score in advanced-stage Hodgkin\u2019s lymphoma: a report from a joint Italian\u2013Danish study","volume":"25","author":"Gallamini","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clml.2018.06.022_bib16","first-page":"1","article-title":"PET-adapted therapy for advanced Hodgkin lymphoma\u2014systematic review","volume":"18","author":"Amitai","year":"2018","journal-title":"Acta Oncol"},{"key":"10.1016\/j.clml.2018.06.022_bib17","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1186\/s12885-015-1193-1","article-title":"Prognostic significance of interim PET\/CT based on visual, SUV-based, and MTV-based assessment in the treatment of peripheral T-cell lymphoma","volume":"15","author":"Jung","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.clml.2018.06.022_bib18","doi-asserted-by":"crossref","first-page":"589","DOI":"10.2967\/jnumed.117.193946","article-title":"Predictive value of PET response combined with baseline metabolic tumor volume in peripheral T-cell lymphoma","volume":"59","author":"Cottereau","year":"2018","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.clml.2018.06.022_bib19","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1038\/sj.leu.2404780","article-title":"Absolute lymphocyte counts predicts response to chemotherapy and survival in diffuse large B-cell lymphoma","volume":"21","author":"Kim","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.clml.2018.06.022_bib20","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1056\/NEJM199811193392104","article-title":"A\u00a0prognostic score for advanced Hodgkin\u2019s disease: international prognostic factors project on advanced Hodgkin\u2019s disease","volume":"339","author":"Hasenclever","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clml.2018.06.022_bib21","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.3109\/10428194.2010.508189","article-title":"Lymphopenia as a prognostic factor in patients with peripheral T-cell lymphoma, unspecified","volume":"10","author":"Castillo","year":"2010","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2018.06.022_bib22","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/ajh.23205","article-title":"The prognostic significance of lymphopenia in peripheral T-cell and natural killer\/T-cell lymphomas: a study of 826 cases from the international peripheral T-cell lymphoma project","volume":"87","author":"Mitrovic","year":"2012","journal-title":"Am J Hematol"},{"key":"10.1016\/j.clml.2018.06.022_bib23","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1080\/10428194.2017.1300891","article-title":"Accuracy of 18-F FDG PET\/CT to detect bone marrow clearance in patients with peripheral T-cell lymphoma\u2014tissue remains the issue","volume":"58","author":"Pham","year":"2017","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clml.2018.06.022_bib24","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00277-011-1353-6","article-title":"Role of FDG-PET\/CT in detecting lymphomatous bone marrow involvement in patients with newly diagnosed broad diffuse B-cell lymphoma","volume":"91","author":"Hong","year":"2012","journal-title":"Ann Hematol"},{"key":"10.1016\/j.clml.2018.06.022_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0170299","article-title":"PET\/CT scanner and bone marrow biopsy in detection of bone marrow involvement in diffuse large B-cell lymphoma","volume":"12","author":"Karak","year":"2017","journal-title":"PLoS One"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265018304208?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265018304208?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:31:14Z","timestamp":1761870674000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265018304208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":25,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S2152265018304208"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2018.06.022","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.733679087.793577564","asserted-by":"object"}]},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Utility of PET-CT for Evaluation of Patients With Peripheral T-cell Lymphoma","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2018.06.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}